Placebo-Controlled Randomized Trial of Adjuvant Imatinib Mesylate Following the Resection of Localized, Primary Gastrointestinal Stromal Tumor (GIST)

BACKGROUND: Gastrointestinal stromal tumor (GIST) is the most common sarcoma of the intestinal tract. The standard treatment of localized, primary GIST has been surgical resection alone. Most GISTs have a mutation in the KIT proto-oncogene, or less commonly in platelet-derived growth factor receptor...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: DeMatteo, Ronald P., Ballman, Karla V., Antonescu, Cristina R., Maki, Robert G., Pisters, Peter W.T., Demetri, George D., Blackstein, Martin E., Blanke, Charles D., von Mehren, Margaret, Brennan, Murray F., Patel, Shreyaskumar, McCarter, Martin D., Polikoff, Jonathan A., Tan, Benjamin R., Owzar, Kouros
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2915459/
https://ncbi.nlm.nih.gov/pubmed/19303137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(09)60500-6
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items